Serum Concentrations of Matrix Metalloproteinase‐1 and Procollagen Type I Carboxy Terminal Propeptide Discriminate Infarct‐Like Myocarditis and Non−ST‐Segment−Elevation Myocardial Infarction
Authors:
- Lucas BacmeisterLBLucas Bacmeister
- Ersin CavusECErsin Cavus
- Sebastian BohnenSBSebastian Bohnen
- Annette BuellesbachABAnnette Buellesbach
- Adrian HeidenreichAHAdrian Heidenreich
- Virginia K. HaackeVHVirginia K. Haacke
- Susanne WeberSWSusanne Weber
- Ingo HilgendorfIHIngo Hilgendorf
- Francisco OjedaFOFrancisco Ojeda
Open Access
- 16 July 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (14) , e034194
Abstract
Background: Biomarkers simplifying the diagnostic workup by discriminating between non–ST‐segment–elevation myocardial infarction (NSTEMI) and infarct‐like myocarditis are an unmet clinical need. Methods and Results: A total of 105 subjects were categorized into groups as follows: ST‐segment−elevation myocardial infarction (n=36), NSTEMI (n=22), infarct‐like myocarditis (n=19), cardiomyopathy‐like myocarditis (n=18), and healthy control (n=10). All subjects underwent cardiac magnetic resonance imaging, and serum concentrations of matrix metalloproteinase‐1 (MMP‐1) and procollagen type I carboxy terminal propeptide (PICP) were measured. Biomarker concentrations in subjects presenting with acute coronary syndrome and non‐ST‐segment‐elevation, for example NSTEMI or infarct‐like myocarditis, categorized as the non−ST‐segment−elevation acute coronary syndrome−like cohort, were of particular interest for this study. Compared with healthy controls, subjects with myocarditis had higher serum concentrations of MMP‐1 and PICP, while no difference was observed in individuals with myocardial infarction. In the non−ST‐segment−elevation acute coronary syndrome−like cohort, MMP‐1 concentrations discriminated infarct‐like myocarditis and NSTEMI with an area under the receiver operating characteristic curve (AUC) of 0.95 (95% CI, 0.89−1.00), whereas high‐sensitivity cardiac troponin T performed inferiorly (AUC, 0.74 [95% CI, 0.58−0.90]; P =0.012). Application of an optimal MMP‐1 cutoff had 94.4% sensitivity (95% CI, 72.7%−99.9%) and 90.9% specificity (95% CI, 70.8%−98.9%) for the diagnosis of infarct‐like myocarditis in this cohort. The AUC of PICP in this context was 0.82 (95% CI, 0.68−0.97). As assessed by likelihood ratio tests, incorporating MMP‐1 or PICP with age and C‐reactive protein into composite prediction models enhanced their diagnostic performance. Conclusions: MMP‐1 and PICP could potentially be useful biomarkers for differentiating between NSTEMI and infarct‐like myocarditis in individuals with non−ST‐segment−elevation acute coronary syndrome‐like presentation, though further research is needed to validate their clinical applicability.Keywords
This publication has 39 references indexed in Scilit:
- The combination of carboxy‐terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy – A multilevel assessment of myocardial fibrosis in dilated cardiomyopathyEuropean Journal of Heart Failure, 2021
- Myocardial Interstitial Fibrosis in Nonischemic Heart Disease, Part 3/4JACC, 2020
- Cardiovascular Magnetic Resonance in Nonischemic Myocardial InflammationJACC, 2018
- Fourth Universal Definition of Myocardial Infarction (2018)JACC, 2018
- Myocarditis or “true” infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease: A meta-analysis of individual patient dataAtherosclerosis, 2015
- Circulating Biomarkers of Myocardial FibrosisJACC, 2015
- CMR in Patients With Severe MyocarditisJACC: Cardiovascular Imaging, 2014
- Cardiovascular Magnetic Resonance in Myocarditis: A JACC White PaperJACC, 2009
- Structure and function of matrix metalloproteinases and TIMPsCardiovascular Research, 2006
- Electrocardiography of myocarditis revisited: Clinical and prognostic significance of electrocardiographic changesAmerican Heart Journal, 1992